Navigation Links
Medinol Receives CE Mark for Presillion(TM) Cobalt Chromium Coronary Stent on Rx System, an Advanced Evolution of the NIR(R) Family of Stents
Date:5/12/2008

Provides the Optimal Combination of Scaffolding, Deliverability and

Conformability

TEL AVIV, Israel, May 12 /PRNewswire/ -- Medinol is proud to announce that it has received CE Mark for its Presillion(TM) CoCr Coronary Stent, enabling physicians to treat coronary artery lesions with a technologically innovative flexible closed cell design stent.

Presillion(TM) preserves the superb scaffolding the unprecedented balance of flexibility and conformability identified with the NIRflex flexible closed cell design. The unique geometry of the Presillion(TM) complies with the long term needs of patients for both safety and efficacy in addition to ease of delivery for the physicians. The alternating rings provide simultaneously optimal flexibility and enhanced scaffolding. Dr. Kobi Richter, chairman of the board and chief technology officer of Medinol says, "Cobalt Chromium enables us to reduce the strut thickness and overall cell size by up to 25% compared to stainless steel while retaining superior scaffolding through the unique flexible closed cell design; this material also maintains a much higher fatigue resistance and radiopacity than the common stainless steel stents."

"Medinol is proud to introduce a new family of stent systems to the market, the first of which is the Presillion(TM). By utilizing its expertise and IP Medinol is proving itself once again as a leading developer, designer and manufacturer of stents and stent systems," says Dr. Judith Richter, chief executive officer for Medinol.

Medinol partnered with Cordis, a Johnson and Johnson company, last year, and will be distributing the Presillion globally. "We are happy that we are able to enrich Cordis's Cath Lab Cubed offer to market," says Dr. Richter.

Recent research recognized the value of Bare Metal Stents and the growing versatility of treatments of complex coronary artery disease. The introduction of the Presillion enhances the physicians' ability to choose the most suitable stent for each patient and the long term benefits provided for each individual vessel and lesion.

The Presillion comes in diameters ranging from 2.5-4.0 mm. and in lengths ranging from 8-32 mm. The Presillion stent system and can be used to treat various lesion types: de novo, restenotic lesions, total occlusions, bifurcations, and acute myocardial infarction.

Medinol continues setting new standards in the stenting industry through design innovation and advance technology manufacturing methods. Medinol is constantly enhancing its technology and producing stenting solutions for: coronary and vascular systems, bifurcation stenting and biliary stenting. Medinol is currently developing advanced technology stents and additional therapeutic solutions for the treatment of vascular disease that will be introduced to the market in the near future.

Contact:

Tamar Hadar

Senior Director, Global Sales & Marketing

Medinol Ltd.

Office: +972-3-7679000 ext. 256

Tamar.Hadar@MEDINOL.COM


'/>"/>
SOURCE Medinol Ltd
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device
2. Strykers Biotech Division Receives FDA Warning Letter
3. Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging
4. Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch
5. Genta Receives Key Patent Related to Oral Gallium Compound G4544
6. QMed, Inc. Receives 2-Year Extension of Medicare Coordinated Care Demonstration Project by CMS
7. Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium
8. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
9. DermaGen AB Receives Over 1 Million Euros From a New Share Issue
10. PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
11. Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
(Date:6/24/2016)... , June 24, 2016 ... the "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural ... Structural electronics involves electronic and/or ... protective structures, replacing dumb structures such as vehicle ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
Breaking Medicine News(10 mins):